A carregar...
The New Immuno-Oncology-Based Therapies and Their Perspectives in Hepatocellular Carcinoma
SIMPLE SUMMARY: Hepatocellular carcinoma is a frequent and poor prognosis tumor, with most patients facing up, soon or later, to systemic therapies. So far, systemic therapies based on tyrosine kinase inhibitor monotherapies have been of modest benefit. The aim of this review article was to characte...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7826922/ https://ncbi.nlm.nih.gov/pubmed/33440630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13020238 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|